 | • レポートコード：MRC2312MG15401 • 出版社/出版日：Market Monitor Global / 2023年12月 • レポート形態：英文、PDF、74ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療機器＆消耗品 |
| Single User | ￥487,500 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥731,250 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートは次の情報を含め、世界の組織質量分析イメージング装置市場規模と予測を収録しています。・世界の組織質量分析イメージング装置市場：売上、2018年-2023年、2024年-2029年 ・世界の組織質量分析イメージング装置市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界の組織質量分析イメージング装置市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「検出チャンネル100以下」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 組織質量分析イメージング装置のグローバル主要企業は、Standard BioTools、 Waters Corporation、 Ionpath、 JEOL、 SHIMADZU、 TransMIT GmbH、 Thermo Fisher Scientific、 Impact Scientific Instrument、 mProbeなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、組織質量分析イメージング装置のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の組織質量分析イメージング装置市場：タイプ別、2018年-2023年、2024年-2029年 世界の組織質量分析イメージング装置市場：タイプ別市場シェア、2022年 ・検出チャンネル100以下、検出チャンネル100以上 世界の組織質量分析イメージング装置市場：用途別、2018年-2023年、2024年-2029年 世界の組織質量分析イメージング装置市場：用途別市場シェア、2022年 ・神経科学、病理学、栄養学、その他 世界の組織質量分析イメージング装置市場：地域・国別、2018年-2023年、2024年-2029年 世界の組織質量分析イメージング装置市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における組織質量分析イメージング装置のグローバル売上、2018年-2023年 ・主要企業における組織質量分析イメージング装置のグローバル売上シェア、2022年 ・主要企業における組織質量分析イメージング装置のグローバル販売量、2018年-2023年 ・主要企業における組織質量分析イメージング装置のグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Standard BioTools、 Waters Corporation、 Ionpath、 JEOL、 SHIMADZU、 TransMIT GmbH、 Thermo Fisher Scientific、 Impact Scientific Instrument、 mProbe ************************************************************* ・調査・分析レポートの概要 組織質量分析イメージング装置市場の定義 市場セグメント 世界の組織質量分析イメージング装置市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の組織質量分析イメージング装置市場規模 世界の組織質量分析イメージング装置市場規模：2022年 VS 2029年 世界の組織質量分析イメージング装置市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの組織質量分析イメージング装置の売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業の組織質量分析イメージング装置製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：検出チャンネル100以下、検出チャンネル100以上 組織質量分析イメージング装置のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：神経科学、病理学、栄養学、その他 組織質量分析イメージング装置の用途別グローバル売上・予測 ・地域別市場分析 地域別組織質量分析イメージング装置市場規模 2022年と2029年 地域別組織質量分析イメージング装置売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Standard BioTools、 Waters Corporation、 Ionpath、 JEOL、 SHIMADZU、 TransMIT GmbH、 Thermo Fisher Scientific、 Impact Scientific Instrument、 mProbe ... |
This research report provides a comprehensive analysis of the Tissue Mass Spectrometry Imaging System market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Tissue Mass Spectrometry Imaging System market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Tissue Mass Spectrometry Imaging System, challenges faced by the industry, and potential opportunities for market players.
The global Tissue Mass Spectrometry Imaging System market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Tissue Mass Spectrometry Imaging System market presents opportunities for various stakeholders, including Neuroscience, Pathology. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Tissue Mass Spectrometry Imaging System market. Additionally, the growing consumer demand present avenues for market expansion.
The global Tissue Mass Spectrometry Imaging System market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Key Features:
The research report on the Tissue Mass Spectrometry Imaging System market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Tissue Mass Spectrometry Imaging System market.
Market Overview: The report provides a comprehensive overview of the Tissue Mass Spectrometry Imaging System market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Detection Channel Is Less Than 100, Detection Channel Is Greater Than 100), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Tissue Mass Spectrometry Imaging System market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Tissue Mass Spectrometry Imaging System market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Tissue Mass Spectrometry Imaging System market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Tissue Mass Spectrometry Imaging System market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Tissue Mass Spectrometry Imaging System market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Tissue Mass Spectrometry Imaging System market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Tissue Mass Spectrometry Imaging System, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Tissue Mass Spectrometry Imaging System market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Tissue Mass Spectrometry Imaging System market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Detection Channel Is Less Than 100
Detection Channel Is Greater Than 100
Market segment by Application
Neuroscience
Pathology
Nutrition
Others
Global Tissue Mass Spectrometry Imaging System Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Standard BioTools
Waters Corporation
Ionpath
JEOL
SHIMADZU
TransMIT GmbH
Thermo Fisher Scientific
Impact Scientific Instrument
mProbe
Outline of Major Chapters:
Chapter 1: Introduces the definition of Tissue Mass Spectrometry Imaging System, market overview.
Chapter 2: Global Tissue Mass Spectrometry Imaging System market size in revenue and volume.
Chapter 3: Detailed analysis of Tissue Mass Spectrometry Imaging System manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Tissue Mass Spectrometry Imaging System in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Tissue Mass Spectrometry Imaging System capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Tissue Mass Spectrometry Imaging System Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Tissue Mass Spectrometry Imaging System Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Tissue Mass Spectrometry Imaging System Overall Market Size
2.1 Global Tissue Mass Spectrometry Imaging System Market Size: 2022 VS 2029
2.2 Global Tissue Mass Spectrometry Imaging System Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Tissue Mass Spectrometry Imaging System Sales: 2018-2029
3 Company Landscape
3.1 Top Tissue Mass Spectrometry Imaging System Players in Global Market
3.2 Top Global Tissue Mass Spectrometry Imaging System Companies Ranked by Revenue
3.3 Global Tissue Mass Spectrometry Imaging System Revenue by Companies
3.4 Global Tissue Mass Spectrometry Imaging System Sales by Companies
3.5 Global Tissue Mass Spectrometry Imaging System Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Tissue Mass Spectrometry Imaging System Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Tissue Mass Spectrometry Imaging System Product Type
3.8 Tier 1, Tier 2 and Tier 3 Tissue Mass Spectrometry Imaging System Players in Global Market
3.8.1 List of Global Tier 1 Tissue Mass Spectrometry Imaging System Companies
3.8.2 List of Global Tier 2 and Tier 3 Tissue Mass Spectrometry Imaging System Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Tissue Mass Spectrometry Imaging System Market Size Markets, 2022 & 2029
4.1.2 Detection Channel Is Less Than 100
4.1.3 Detection Channel Is Greater Than 100
4.2 By Type – Global Tissue Mass Spectrometry Imaging System Revenue & Forecasts
4.2.1 By Type – Global Tissue Mass Spectrometry Imaging System Revenue, 2018-2023
4.2.2 By Type – Global Tissue Mass Spectrometry Imaging System Revenue, 2024-2029
4.2.3 By Type – Global Tissue Mass Spectrometry Imaging System Revenue Market Share, 2018-2029
4.3 By Type – Global Tissue Mass Spectrometry Imaging System Sales & Forecasts
4.3.1 By Type – Global Tissue Mass Spectrometry Imaging System Sales, 2018-2023
4.3.2 By Type – Global Tissue Mass Spectrometry Imaging System Sales, 2024-2029
4.3.3 By Type – Global Tissue Mass Spectrometry Imaging System Sales Market Share, 2018-2029
4.4 By Type – Global Tissue Mass Spectrometry Imaging System Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Tissue Mass Spectrometry Imaging System Market Size, 2022 & 2029
5.1.2 Neuroscience
5.1.3 Pathology
5.1.4 Nutrition
5.1.5 Others
5.2 By Application – Global Tissue Mass Spectrometry Imaging System Revenue & Forecasts
5.2.1 By Application – Global Tissue Mass Spectrometry Imaging System Revenue, 2018-2023
5.2.2 By Application – Global Tissue Mass Spectrometry Imaging System Revenue, 2024-2029
5.2.3 By Application – Global Tissue Mass Spectrometry Imaging System Revenue Market Share, 2018-2029
5.3 By Application – Global Tissue Mass Spectrometry Imaging System Sales & Forecasts
5.3.1 By Application – Global Tissue Mass Spectrometry Imaging System Sales, 2018-2023
5.3.2 By Application – Global Tissue Mass Spectrometry Imaging System Sales, 2024-2029
5.3.3 By Application – Global Tissue Mass Spectrometry Imaging System Sales Market Share, 2018-2029
5.4 By Application – Global Tissue Mass Spectrometry Imaging System Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Tissue Mass Spectrometry Imaging System Market Size, 2022 & 2029
6.2 By Region – Global Tissue Mass Spectrometry Imaging System Revenue & Forecasts
6.2.1 By Region – Global Tissue Mass Spectrometry Imaging System Revenue, 2018-2023
6.2.2 By Region – Global Tissue Mass Spectrometry Imaging System Revenue, 2024-2029
6.2.3 By Region – Global Tissue Mass Spectrometry Imaging System Revenue Market Share, 2018-2029
6.3 By Region – Global Tissue Mass Spectrometry Imaging System Sales & Forecasts
6.3.1 By Region – Global Tissue Mass Spectrometry Imaging System Sales, 2018-2023
6.3.2 By Region – Global Tissue Mass Spectrometry Imaging System Sales, 2024-2029
6.3.3 By Region – Global Tissue Mass Spectrometry Imaging System Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Tissue Mass Spectrometry Imaging System Revenue, 2018-2029
6.4.2 By Country – North America Tissue Mass Spectrometry Imaging System Sales, 2018-2029
6.4.3 US Tissue Mass Spectrometry Imaging System Market Size, 2018-2029
6.4.4 Canada Tissue Mass Spectrometry Imaging System Market Size, 2018-2029
6.4.5 Mexico Tissue Mass Spectrometry Imaging System Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Tissue Mass Spectrometry Imaging System Revenue, 2018-2029
6.5.2 By Country – Europe Tissue Mass Spectrometry Imaging System Sales, 2018-2029
6.5.3 Germany Tissue Mass Spectrometry Imaging System Market Size, 2018-2029
6.5.4 France Tissue Mass Spectrometry Imaging System Market Size, 2018-2029
6.5.5 U.K. Tissue Mass Spectrometry Imaging System Market Size, 2018-2029
6.5.6 Italy Tissue Mass Spectrometry Imaging System Market Size, 2018-2029
6.5.7 Russia Tissue Mass Spectrometry Imaging System Market Size, 2018-2029
6.5.8 Nordic Countries Tissue Mass Spectrometry Imaging System Market Size, 2018-2029
6.5.9 Benelux Tissue Mass Spectrometry Imaging System Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Tissue Mass Spectrometry Imaging System Revenue, 2018-2029
6.6.2 By Region – Asia Tissue Mass Spectrometry Imaging System Sales, 2018-2029
6.6.3 China Tissue Mass Spectrometry Imaging System Market Size, 2018-2029
6.6.4 Japan Tissue Mass Spectrometry Imaging System Market Size, 2018-2029
6.6.5 South Korea Tissue Mass Spectrometry Imaging System Market Size, 2018-2029
6.6.6 Southeast Asia Tissue Mass Spectrometry Imaging System Market Size, 2018-2029
6.6.7 India Tissue Mass Spectrometry Imaging System Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Tissue Mass Spectrometry Imaging System Revenue, 2018-2029
6.7.2 By Country – South America Tissue Mass Spectrometry Imaging System Sales, 2018-2029
6.7.3 Brazil Tissue Mass Spectrometry Imaging System Market Size, 2018-2029
6.7.4 Argentina Tissue Mass Spectrometry Imaging System Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Tissue Mass Spectrometry Imaging System Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Tissue Mass Spectrometry Imaging System Sales, 2018-2029
6.8.3 Turkey Tissue Mass Spectrometry Imaging System Market Size, 2018-2029
6.8.4 Israel Tissue Mass Spectrometry Imaging System Market Size, 2018-2029
6.8.5 Saudi Arabia Tissue Mass Spectrometry Imaging System Market Size, 2018-2029
6.8.6 UAE Tissue Mass Spectrometry Imaging System Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Standard BioTools
7.1.1 Standard BioTools Company Summary
7.1.2 Standard BioTools Business Overview
7.1.3 Standard BioTools Tissue Mass Spectrometry Imaging System Major Product Offerings
7.1.4 Standard BioTools Tissue Mass Spectrometry Imaging System Sales and Revenue in Global (2018-2023)
7.1.5 Standard BioTools Key News & Latest Developments
7.2 Waters Corporation
7.2.1 Waters Corporation Company Summary
7.2.2 Waters Corporation Business Overview
7.2.3 Waters Corporation Tissue Mass Spectrometry Imaging System Major Product Offerings
7.2.4 Waters Corporation Tissue Mass Spectrometry Imaging System Sales and Revenue in Global (2018-2023)
7.2.5 Waters Corporation Key News & Latest Developments
7.3 Ionpath
7.3.1 Ionpath Company Summary
7.3.2 Ionpath Business Overview
7.3.3 Ionpath Tissue Mass Spectrometry Imaging System Major Product Offerings
7.3.4 Ionpath Tissue Mass Spectrometry Imaging System Sales and Revenue in Global (2018-2023)
7.3.5 Ionpath Key News & Latest Developments
7.4 JEOL
7.4.1 JEOL Company Summary
7.4.2 JEOL Business Overview
7.4.3 JEOL Tissue Mass Spectrometry Imaging System Major Product Offerings
7.4.4 JEOL Tissue Mass Spectrometry Imaging System Sales and Revenue in Global (2018-2023)
7.4.5 JEOL Key News & Latest Developments
7.5 SHIMADZU
7.5.1 SHIMADZU Company Summary
7.5.2 SHIMADZU Business Overview
7.5.3 SHIMADZU Tissue Mass Spectrometry Imaging System Major Product Offerings
7.5.4 SHIMADZU Tissue Mass Spectrometry Imaging System Sales and Revenue in Global (2018-2023)
7.5.5 SHIMADZU Key News & Latest Developments
7.6 TransMIT GmbH
7.6.1 TransMIT GmbH Company Summary
7.6.2 TransMIT GmbH Business Overview
7.6.3 TransMIT GmbH Tissue Mass Spectrometry Imaging System Major Product Offerings
7.6.4 TransMIT GmbH Tissue Mass Spectrometry Imaging System Sales and Revenue in Global (2018-2023)
7.6.5 TransMIT GmbH Key News & Latest Developments
7.7 Thermo Fisher Scientific
7.7.1 Thermo Fisher Scientific Company Summary
7.7.2 Thermo Fisher Scientific Business Overview
7.7.3 Thermo Fisher Scientific Tissue Mass Spectrometry Imaging System Major Product Offerings
7.7.4 Thermo Fisher Scientific Tissue Mass Spectrometry Imaging System Sales and Revenue in Global (2018-2023)
7.7.5 Thermo Fisher Scientific Key News & Latest Developments
7.8 Impact Scientific Instrument
7.8.1 Impact Scientific Instrument Company Summary
7.8.2 Impact Scientific Instrument Business Overview
7.8.3 Impact Scientific Instrument Tissue Mass Spectrometry Imaging System Major Product Offerings
7.8.4 Impact Scientific Instrument Tissue Mass Spectrometry Imaging System Sales and Revenue in Global (2018-2023)
7.8.5 Impact Scientific Instrument Key News & Latest Developments
7.9 mProbe
7.9.1 mProbe Company Summary
7.9.2 mProbe Business Overview
7.9.3 mProbe Tissue Mass Spectrometry Imaging System Major Product Offerings
7.9.4 mProbe Tissue Mass Spectrometry Imaging System Sales and Revenue in Global (2018-2023)
7.9.5 mProbe Key News & Latest Developments
8 Global Tissue Mass Spectrometry Imaging System Production Capacity, Analysis
8.1 Global Tissue Mass Spectrometry Imaging System Production Capacity, 2018-2029
8.2 Tissue Mass Spectrometry Imaging System Production Capacity of Key Manufacturers in Global Market
8.3 Global Tissue Mass Spectrometry Imaging System Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Tissue Mass Spectrometry Imaging System Supply Chain Analysis
10.1 Tissue Mass Spectrometry Imaging System Industry Value Chain
10.2 Tissue Mass Spectrometry Imaging System Upstream Market
10.3 Tissue Mass Spectrometry Imaging System Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Tissue Mass Spectrometry Imaging System Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
